| Stage | DGX | % of rev | LMRI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.1B | 100.00% | $264M | 100.00% | DGX ×11.72 |
| Gross profit | $1.0B | 33.65% | $264M | 100.00% | LMRI +66.4pp |
| Operating income | $479M | 15.47% | $4M | 1.67% | DGX +13.8pp |
| Pre-tax income | $416M | 13.43% | $6M | 2.18% | DGX +11.2pp |
| Net income | $326M | 10.53% | $3M | 1.04% | DGX +9.5pp |
| Stage | DGX | LMRI | Gap · A − B |
|---|---|---|---|
| Revenue | $3.1B100.00% | $264M100.00% | DGX ×11.72 |
| Gross profit | 33.65%$1.0B | 100.00%$264M | LMRI +66.4pp |
| Operating income | 15.47%$479M | 1.67%$4M | DGX +13.8pp |
| Pre-tax income | 13.43%$416M | 2.18%$6M | DGX +11.2pp |
| Net income |
| 10.53%$326M |
| 1.04%$3M |
| DGX +9.5pp |